Watch · Quality 22/100
Simple research view
WST · West Pharmaceutical Services, Inc.
$331.25 latest stored close
1 independent risk warning also present. Review before relying on the bullish setup.
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$WST
West Pharmaceutical Services, Inc.West Pharmaceutical Services, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $23B.
⚠ Risk Signals
Rising Wedge
prior_advance=60.7%, converging=yes, narrowing=52%, touches=upper:2/lower:2, trigger=broke
Bearish structure on the daily chart — a heads-up for anyone holding, not a short signal. Does not affect the bullish setup score.
Council read · 6 methods
Watch — evidence is building
0 buyable · 4 watch · 2 avoid. Review the observed passes and blockers before reading the chart.
Earnings-risk mode
Normal technical setup
Thursday, July 23, 2026
Time not confirmed
No sourced report session or clock time
Deterministic evidence
WST+0.93%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
AI interpretation (optional)
Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.
Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.WST Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Setup Quality
D
2/7 signals
Score trend
✓
Stage 2 · Advancing
✗
Power Trend
✗ RS New High
✓ Trend 6/8
✗
No Pattern
✗ CANSLIM 59.7 (C)
✗ Gatekeeper
Base #1 (A)
Technical Analysis Report Card
$WST · $331.25 · as of 2026-07-27 · multi-factor read
50
/ 100
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▬ Sideways / consolidating
Monthly
▬ Sideways / consolidating
Moving Averages
50-day$335.31 ↓
100-day$301.89 ↑
200-day$283.40 ↑
Bullish (50 > 200)
RSI (14)
Reading39.1 · Bearish
Bearish momentum — sellers in control.
MACD (12/26/9)
StateWeakening
Histogram-4.448
Weakening — MACD slipped below its signal line. Histogram contracting.
Bollinger Bands (20,2)
%B / Width-14% · 10.6%
Piercing the lower band — capitulation or strong selling.
Volume · Buyer vs Seller
Up/Down vol0.92 · Neutral
Rel volume2.02×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is expanding versus its baseline.
Support & Resistance
R · $336.82swing level
R · $367.66swing level
R · $386.0052-week high
Price · $331.25now
S · $321.94swing level
S · $295.90swing level
S · $240.16swing level
Fibonacci · Uptrend swing
23.6%$348.59
38.2%$325.45
50.0%$306.75
61.8%$288.04
78.6%$261.41
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for WST — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Above 200-day MA50/200 bullish
Want this read in a legend's voice?
💬 Ask a Legend about WST
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
🟡 4 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini C
Trend-template read: fails Price > 50-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $331.25, MA150 $286.64, MA200 $283.40
1.2 150-day MA > 200-day MAMA150 $286.64 vs MA200 $283.40
Failing evidence
1.5 Price > 50-day MAPrice $331.25 vs MA50 $335.31
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 55
Avoid
O'Neil D
CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.
Passing evidence
A: Annual earnings & revenue qualityRev +6.2% | ROE 17.9%
N: Near 52-week high or RS line new high14.2% below high | RS line new high: False
Failing evidence
C: Quarterly EPS acceleration ≥ 25%+4.4% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 55
Watch
Weinstein C
Stage-analysis read: Stage 2 is present; 2 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $331.25 vs MA200 $283.40
Failing evidence
Relative strength ≥ 60RS 55
Weekly price coiling (Stage 2 consolidation)Tightening weekly range confirms base
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$331.25
Volume vs average2.02x
Failing evidence
Relative strengthRS 55
Watch
Darvas B
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$331.25
Volume vs average2.02x
Failing evidence
Relative strengthRS 55
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$331.25
Volume vs average2.02x
Failing evidence
Relative strengthRS 55
Breakout Health
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▼ Falling
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +3
Fundamentals & leadership quality — Minervini SEPA criteria · 4/7 met
B
4/7 SEPA
Separate score from the 8-point Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
+4%
Revenue growth ≥20% YoY
+6%
Gross margin ≥30%
36%
ROE ≥17%
18%
RS rating ≥80 (leadership)
55
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-14.2%
Method Playbook
📋 Trade it like O'Neil
EXACT LEVELS · PRO
O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro levelPublished-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis
Wyckoff SOS
⚠ Volatility widening into breakout
⚠ Extended past buy zone
⚠ 3rd-stage base
⚠ Rising wedge (broke lower)
⚠ Not actionable yet
47.0
score
RS Score
55
Trend
6/8 ✗
CANSLIM
59.7* (C)
range low: 236.337
range high: 309.995
range pct: 0.312
sos thrust: 0.147
sos vol ratio: 1.935
sos bars ago: 2
near lps: ✓
validation reason: valid generic setup
multi tf evaluated: ✓
multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS
SOS: breakout above range_high=309.99, thrust=14.7%, vol=1.9x avg, lps=near, 2 bars ago | Moderate trend (6/8) | High-confidence pattern (85%) | Volume surging | Stage 2 | Recent gap-up (2d ago) | Readiness 62/100 (early) | CANSLIM 59.7 (C) | ⚠ Volatility widening into breakout; Extended past buy zone; 3rd-stage base; Rising wedge (broke lower); Not actionable yet
The Universal Edge Check
The panel is uneasy
Too many universals unmet — this leans closer to a guess than a trade.
2/7
universals met
- In a confirmed uptrend Stage 2 · Trend 6/8
- Risk is defined No stop — undefined risk
- Asymmetric reward No target set
- Not chasing (in range) Pivot distance unknown
- Volume confirms 2.0× average
- Clear of earnings in -5 days — event risk
- A relative-strength leader RS 55 — laggard
Minervini Trend Template
6/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$331.25 vs SMA150 $286.64 / SMA200 $283.40
SMA 150 above SMA 200
SMA150 $286.64 vs SMA200 $283.40
SMA 200 trending up
Slope +9.49 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $335.31
Price above SMA 50
$331.25 vs SMA50 $335.31
30%+ above 52W low
+48.0% from $223.83
Within 25% of 52W high
-14.2% from $386.00
RS score above 70
RS 55
Fundamentals
52W Range
66%
Mkt Cap SEC
23.3B
EPS QoQ
+4%
Rev YoY
+6%
ROE
18%
Gross Margin
36%
D/E
0.07
EPS TTM
$6.79
P/E TTM
48.8x
Float
70M
Insider
No Buy
Company
Legend AI snapshot
West Pharmaceutical Services, Inc.
$331.25latest close
$23.3Bmarket cap
55RS rank
47setup score
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C
59.7* CANSLIM
* disqualified on C, M
C · Curr. EPS
62
A · Annual EPS
71
N · New Highs
40
S · Supply/Demand
100
L · Leader RS
55
I · Inst. Spons.
50
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
7/8
W. RS
80
W. Support
$223.83
W. Resist
$386.00
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
4× streakJul 28
Wyckoff SOS
✓ Gate
55
Jul 28
Wyckoff SOS
47
Jul 24
Wyckoff SOS
✓ Gate
55
+0.9%
Jul 23
Power Play
✓ Gate
55
-6.8%
Get the full picture on WST
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.
Start 7-Day Free Trial